Estimates Revisions Paradigm Biopharmaceuticals Limited
Stocks
PAR
AU000000PAR5
Biotechnology & Medical Research
|
Market Closed -
Australian S.E.
02:10:26 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 0.2450 AUD | -2.00% |
|
+2.08% | -27.94% |
| 09-14 | Paradigm Biopharmaceuticals Names Chief Medical Officer | MT |
| 09-10 | Paradigm Biopharmaceuticals Draws Down Final $2 Million of Tranche 4 From Convertible Note Facility; Shares Down 13% | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- PAR Stock
- Consensus Paradigm Biopharmaceuticals Limited
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
